#USA #Scottsdale #Jetstream Venture #ImageAiD #Moonrise Medical

Jetstream Venture Fund Expands Healthtech Portfolio

In a significant move for the healthtech sector, Jetstream Venture Fund has announced its latest investments in two innovative companies: ImageAiD and Moonrise Medical. Both firms are spearheading advancements in AI-driven vascular diagnostic platforms, designed to enhance the early detection and management of Peripheral Artery Disease (PAD), a condition that impacts over 200 million individuals worldwide, including 12 million in the United States alone.

Transforming Healthcare Delivery

Jetstream's investment strategy hinges on its extensive leadership team's background in clinical operations and healthcare ventures, allowing it to access a unique pipeline of high-potential medical startups. While many traditional retail platforms often overlook specialized medical innovations, Jetstream strategically utilizes its deep network to foster groundbreaking technologies, shifting advanced diagnostic tools to the forefront of patient care.

About the Companies

1. ImageAiD: This company is revolutionizing the way PAD is detected. With the backing of research validated by the Mayo Clinic, ImageAiD utilizes a handheld Doppler device combined with predictive AI software. This technology permits early identification of PAD, often years before any physical symptoms emerge, all within primary care environments.

2. Moonrise Medical: Focused on enhancing vascular health evaluations, Moonrise Medical automates complex Doppler ultrasound assessments and Pedal Acceleration Time (PAT) calculations. This innovation empowers general healthcare providers to conduct precise vascular health assessments without the need for specialized sonographers. The automation of these processes dramatically enhances efficiency and accuracy in diagnostics.

A Hands-On Approach to Medical Innovation

Mike Shufeldt, Portfolio Manager at Jetstream, emphasized the urgency for a proactive approach to vascular care, stating, "Patients are often diagnosed only after irreversible tissue damage occurs. Our leadership team's decades of experience in clinical medicine and healthtech enables us to pinpoint promising medical platforms early, securing access to potential high-value deals that conventional venture networks might miss. Both ImageAiD and Moonrise Medical embody our fundamental belief in leveraging software and automation to elevate sophisticated diagnostics into routine clinical workflows."

Democratizing Investment in Healthtech

Jetstream Venture Fund is committed to making institutional-quality investment opportunities available to a broader audience. By maintaining a minimum investment threshold of $5,000 and not charging carried interest, the fund democratizes access to lucrative healthcare ventures, joining esteemed projects like SpaceX and Shield AI in its portfolio.

Interested investors can learn more about joining Jetstream’s efforts and exploring its current portfolio through a scheduled call or by visiting their website for more insights.

About Jetstream Venture Fund

Managed by Xcellerant Ventures and Sweater Industries LLC, Jetstream Venture Fund operates as an interval fund that focuses on providing early-stage investments in high-growth private companies. The firm’s strategy enables lower barrier entries into the venture capital space, providing innovative investment options in the healthcare sector and beyond. For more detailed information, potential investors are encouraged to visit www.jvf.vc.

Cautionary Note: Prospective investors are urged to carefully consider the investment objectives, risks, charges, and expenses associated with the Fund prior to making any decisions. The prospectus includes crucial information and can be accessed via the mentioned website. It’s essential to read through the prospectus in its entirety before committing any funds.